Sunday, August 03, 2014 3:25:38 PM
Below is part of what I got from IR last week:
"Please note that there are several other meaningful developmental milestones to look forward to, including, (1) the announcement of our strategy of MST-188 for the treatment of heart failure; (2) plans to evaluate MST-188 in a trauma model; and (3) plans to report results from a Phase 2 study of AIR001 in pulmonary arterial hypertension and announce our overall clinical strategy for AIR001, among others."
GLTA
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM